Arcus Biosciences Announces Clinical Trial Collaboration …
WEB2 days ago · HAYWARD, Calif., October 02, 2024--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies ...
Arcus Biosciences, Inc. (RCUS) Latest Stock News & Headlines
WEBGet the latest Arcus Biosciences, Inc. (RCUS) stock news and headlines to help you in your trading and investing decisions.
Arcus and AstraZeneca enter trial collaboration for renal cancer …
WEB1 day ago · AZN. Arcus Biosciences has announced a clinical trial partnership with AstraZeneca to assess the combination of casdatifan (AB521) and volrustomig in patients with clear cell renal cell carcinoma ...
Arcus Announces Clinical Trial Collaboration With AstraZeneca To ...
WEB2 days ago · (RTTNews) - Arcus Biosciences, Inc. (RCUS), Wednesday announced a clinical trial collaboration agreement with AstraZeneca (AZN) to evaluate casdatifan in combination with volrustomig for the ...
Arcus Biosciences - Arcus Biosciences Announces Clinical Trial ...
WEB2 days ago · Arcus and AstraZeneca to evaluate their respective molecules in combination to establish a potential first- and best-in-class treatment for clear cell renal cell carcinoma (ccRCC) This is the second clinical collaboration between Arcus and AstraZeneca Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and ...
Gilead and Arcus Announce Amended Collaboration and ... - Gilead Sciences
WEBJan 29, 2024 · Gilead and Arcus have reprioritized the joint domvanalimab development program to focus on advancing and potentially accelerating the Phase 3 studies STAR-121 (lung cancer) and STAR-221 (gastrointestinal cancer), which are both expected to be fully enrolled by year-end.
Arcus Biosciences - Investors & Media
WEBAug 8, 2024 · Investor Overview. Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer.
Arcus Biosciences, Inc. (RCUS) Stock Price, Quote, News & Analysis
WEB2 days ago · A high-level overview of Arcus Biosciences, Inc. (RCUS) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Arcus Biosciences | Pursuit of Cures for Cancer
WEBArcus is at the forefront of designing combination therapies, with best-in-class potential, in our relentless pursuit of cures for cancer. Featured Arcus News: Arcus Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
Optimistic Buy Rating for Arcus Biosciences Amid Promising …
WEBJan 24, 2024 · Mizuho Securities analyst Mara Goldstein maintained a Buy rating on Arcus Biosciences (RCUS – Research Report) on January 22 and set a price target of $51.00. Mara Goldstein has given her Buy ...